The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Membranoproliferative Glomerulonephritis Type II (Dense Deposit Disease): An Update
Abstract
Membranoproliferative glomerulonephritis type II (MPGN II) is a rare disease characterized by the deposition of abnormal electron-dense material within the glomerular basement membrane of the kidney and often within Bruch's membrane in the eye. The diagnosis is made in most patients between the ages of 5 and 15 yr, and within 10 yr, approximately half progress to end-stage renal disease, occasionally with the late comorbidity of visual impairment. The pathophysiologic basis of MPGN II is associated with the uncontrolled systemic activation of the alternative pathway (AP) of the complement cascade. In most patients, loss of complement regulation is caused by C3 nephritic factor, an autoantibody directed against the C3 convertase of the AP, but in some patients, mutations in the factor H gene have been identified. For the latter patients, plasma replacement therapy prevents renal failure, but for the majority of patients, there is no proven effective treatment. The disease recurs in virtually all renal allografts, and a high percentage of these ultimately fail. The development of molecular diagnostic tools and new therapies directed at controlling the AP of the complement cascade either locally in the kidney or at the systemic level may lead to effective treatments for MPGN II.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H.-H., Remuzzi, G., Snapinn, S. M., Zhang, Z., & Shahinfar, S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011161 · Cited by 7,493
Towards a network theory of the immune system.
Jerne, N. K. (1974) · PubMed · Cited by 3,362
(2006) · Elsevier eBooks · doi:10.1016/b978-0-12-595961-2.x5000-8 · Cited by 962
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910 · cited 1×
“Angiotensin-converting enzyme inhibitors and angiotensin II type-1 receptor blockers decrease proteinuria in many glomerular diseases and slow progression to renal failure (93,94).”
BackgroundThe human complement factor H: functional roles, genetic variations and disease associations
RODRIGUEZDECORDOBA, S., ESPARZAGORDILLO, J., GOICOECHEADEJORGE, E., LOPEZTRASCASA, M., & SANCHEZCORRAL, P. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.02.005 · Cited by 574
Control of the amplification convertase of complement by the plasma protein beta1H.
Weiler, J. M., Daha, M. R., Austen, K. F., & Fearon, D. T. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.9.3268 · Cited by 570
Orth, S. R., & Ritz, E. (1998) · New England Journal of Medicine · doi:10.1056/nejm199804233381707 · Cited by 533
Pickering, M. C., Cook, H. T., Warren, J., Bygrave, A. E., Moss, J., Walport, M. J., & Botto, M. (2002) · Nature Genetics · doi:10.1038/ng912 · Cited by 518
Self-citationBasta, M., & Dalakas, M. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117520 · Cited by 396
Pendergraft, W. F., Preston, G. A., Shah, R. R., Tropsha, A., Carter, C. W., Jennette, J. C., & Falk, R. J. (2004) · Nature Medicine · doi:10.1038/nm968 · Cited by 379
Self-citationDragon-Durey, M.-A., Frémeaux-Bacchi, V., Loirat, C., Blouin, J., Niaudet, P., Deschenes, G., Coppo, P., Herman Fridman, W., & Weiss, L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000115702.28859.a7 · Cited by 355
Chen, B. J. (2001) · Leukemia & Lymphoma · doi:10.3109/10428190109064582 · Cited by 301
Misra, A., Peethambaram, A., & Garg, A. (2004) · Medicine · doi:10.1097/01.md.0000111061.69212.59 · Cited by 285
The role of podocytes in glomerular pathobiology
Asanuma, K., & Mundel, P. (2003) · Clinical and Experimental Nephrology · doi:10.1007/s10157-003-0259-6 · Cited by 262
Structure–function relationships of complement receptor type 1
Krych‐Goldberg, M., & Atkinson, J. P. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800110.x · Cited by 257
Molecular basis of glomerular permselectivity
Tryggvason, K., & Wartiovaara, J. (2001) · Current Opinion in Nephrology and Hypertension · doi:10.1097/00041552-200107000-00009 · Cited by 238
Structure and flexibility of the multiple domain proteins that regulate complement activation
Kirkitadze, M. D., & Barlow, P. N. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1800113.x · Cited by 204
Pathogenesis of lesions in late age-related macular disease
Holz, F. G., Pauleikhoff, D., Klein, R., & Bird, A. C. (2004) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2003.11.026 · Cited by 203 · cited 1×
“deposits varies among patients (4,15,16) and initially has little”
BackgroundDense deposit disease: A variant of membranoproliferative glomerulonephritis
Habib, R., Gubler, M.-C., Loirat, C., Maïz, H. B., & Levy, M. (1975) · Kidney International · doi:10.1038/ki.1975.32 · Cited by 202
Wilson, J. G., Murphy, E. E., Wong, W. W., Klickstein, L. B., Weis, J. H., & Fearon, D. T. (1986) · The Journal of experimental medicine · doi:10.1084/jem.164.1.50 · Cited by 187
Pangburn, M. K., & Müller-Eberhard, H. J. (1986) · Biochemical Journal · doi:10.1042/bj2350723 · Cited by 182
Nephritogenic lambda light chain dimer: a unique human miniautoantibody against complement factor H.
Jokiranta, T. S., Solomon, A., Pangburn, M. K., Pf, Z., & Meri, S. (1999) · PubMed · Cited by 181
Self-citationAult, B. H., Schmidt, B. Z., Fowler, N. L., Kashtan, C. E., Ahmed, A. E., Vogt, B. A., & Colten, H. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.40.25168 · Cited by 159
Tarshish, P., Bernstein, J., Tobin, J. N., et al. (1992) · Pediatric Nephrology · doi:10.1007/bf00866289 · Cited by 136
Meri, S., & Pangburn, M. K. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1008 · Cited by 133
Self-citationC3b covalently bound to IgG demonstrates a reduced rate of inactivation by factors H and I.
Fries, L. F., Gaither, T. A., Hammer, C. H., & Frank, M. M. (1984) · The Journal of Experimental Medicine · doi:10.1084/jem.160.6.1640 · Cited by 133
Moulds, J. M., Nickells, M. W., Moulds, J. J., et al. (1991) · The Journal of Experimental Medicine · doi:10.1084/jem.173.5.1159 · Cited by 110
Schwertz, R., Rother, U., Anders, D., Gretz, N., Scharer, K., & Kirschfink, M. (2001) · Pediatric Allergy and Immunology · doi:10.1034/j.1399-3038.2001.012003166.x · Cited by 108
Self-citationPascual, M. A., Steiger, G., Sadallah, S., Paccaud, J. P., Carpentier, J. L., James, R., & Schifferli, J. A. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.889 · Cited by 98
The idiotypic network in autoimmunity: antibodies that bind antibodies that bind antibodies
Shoenfeld, Y. (2003) · Nature Medicine · doi:10.1038/nm0104-17 · Cited by 96
Critical self-epitopes are key to the understanding of self-tolerance and autoimmunity
Dighiero, G., & Rose, N. R. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01509-1 · Cited by 84
Self-citationDonadío, J. V., & OFFORD, K. P. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80143-x · Cited by 79
The Molecular Basis for Hereditary Porcine Membranoproliferative Glomerulonephritis Type II
Hegasy, G. A., Manuelian, T., Högåsen, K., Jansen, J. H., & Zipfel, P. F. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64481-1 · Cited by 77
Self-citationDuvall-Young, J., Short, C. D., Raines, M. F., Gokal, R., & Lawler, W. (1989) · British Journal of Ophthalmology · doi:10.1136/bjo.73.11.900 · Cited by 74
Hong, Y., Zhou, W., Li, K., & Sacks, S. H. (2002) · Kidney International · doi:10.1111/j.1523-1755.2002.kid586.x · Cited by 71
Glomerular epithelial alterations resulting from sialic acid surface coat removal
Andrews, P. M. (1979) · Kidney International · doi:10.1038/ki.1979.49 · Cited by 70
Renal Disease in Partial Lipodystrophy
Eisinger, A. J., Shortland, J. R., & Moorhead, P. J. (1972) · QJM · doi:10.1093/oxfordjournals.qjmed.a067312 · Cited by 70
Colville, D. J., Guymer, R. H., Sinclair, R. A., & Savige, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00665-6 · Cited by 63
In situ complement activation in porcine membranoproliferative glomerulonephritis type II
Jansen, J. H., Högåsen, K., Harboe, M., & Hovig, T. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00765.x · Cited by 58
Daha, M. R., & van Es, L. A. (1981) · PubMed · Cited by 54
McEnery, P. T. (1990) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)82712-x · Cited by 53
FHR-4A: a new factor H-related protein is encoded by the human FHR-4 gene
Józsi, M., Richter, H., Löschmann, I., Skerka, C., Buck, F., Beisiegel†, U., Erdei, A., & Zipfel, P. F. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201324 · Cited by 52
Self-citationJelezarova, E., Vogt, A. M., & Lutz, H. U. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490217 · Cited by 50
Self-citationHyperlipidemia and thrombotic complications in patients with membranous nephropathy
Nickolas, T. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00058-5 · Cited by 50
Extraglomerular dense deposits in dense deposit disease.
Thorner, P. S., & Baumal, R. (1982) · PubMed · Cited by 20
Nevins, T. E. (1985) · PubMed · Cited by 19
Joh, K., Aizawa, S., Matsuyama, N., Yamaguchi, Y., KITAJIMA, T., Sakai, O., Mochizuki, H., Usui, N., Hamaguchi, K., & Mitarai, T. (1993) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1993.tb03231.x · Cited by 17
Simon, P., Ramée, M. P., Ang, K. S., & Cam, G. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000184108 · Cited by 16
The effect of locally synthesised complement on acute renal allograft rejection
Sacks, S. H., & Zhou, W. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0454-7 · Cited by 15
[Immunoglobulin A glomerulonephritis. Epidemiology in a population of 250 000 inhabitants].
Simon, P., Ang, K. S., Bavay, P., Cloup, C., Jp, M., & Ramée, M. P. (1984) · PubMed · Cited by 14
Cited by
Complement C3 variant and the risk of age-related macular degeneration
Yates, J. R. W., Sepp, T., Matharu, B. K., Khan, J. C., Thurlby, D. A., Shahid, H., Clayton, D. G., Hayward, C., Morgan, J., Wright, A. F., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072618 · Cited by 829
C3 glomerulopathy: consensus report
Pickering, M. C., D'Agati, V. D., Nester, C. M., Smith, R. J., Haas, M., Appel, G. B., Alpers, C. E., Bajema, I. M., Bedrosian, C., Braun, M., et al. (2013) · Kidney International · doi:10.1038/ki.2013.377 · Cited by 653
Self-citationAge‐related macular degeneration—emerging pathogenetic and therapeutic concepts
Gehrs, K. M., Anderson, D. H., Johnson, L. V., & Hageman, G. S. (2006) · Annals of Medicine · doi:10.1080/07853890600946724 · Cited by 631
Self-citationServais, A., Noël, L.-H., Roumenina, L. T., Le Quintrec, M., Ngo, S., Dragon-Durey, M.-A., Macher, M.-A., Zuber, J., Karras, A., Provot, F., et al. (2012) · Kidney International · doi:10.1038/ki.2012.63 · Cited by 575
Membranoproliferative Glomerulonephritis — A New Look at an Old Entity
Sethi, S., & Fervenza, F. C. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1108178 · Cited by 565
Self-citation
Metadata
- Authors
- Appel, G. B., Cook, H. T., Hageman, G., Jennette, J. C., Kashgarian, M., Kirschfink, M., Lambris, J. D., Lanning, L., Lutz, H. U., Meri, S., Rose, N. R., Salant, D. J., Sethi, S., Smith, R. J. H., Smoyer, W., Tully, H. F., Tully, S. P., Walker, P., Welsh, M., Wu[Combining Diaeresis]rzner, R., & Zipfel, P. F.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2005-05
- Volume
- 16
- Issue
- 5
- Pages
- 1392-1403
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2162002618
- Cited by
- 380
- References
- 50
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.